897926-35-1

Basic information

• Product Name: 2-Chloro-N-(4-chlorophenethyl)propan-1-aMine
• Synonyms: 2-Chloro-N-(4-chlorophenethyl)propan-1-aMine;BenzeneethanaMine, 4-chloro-N-(2-chloropropyl)-;4-Chloro-N-(2-chloropropyl)benzeneethanamine
• CAS NO: 897926-35-1
• Molecular Formula: C₁₁H₁₅Cl₂N
• Molecular Weight: 232.1495
• Mol File: 897926-35-1.mol

Chemical Properties

• Boiling Point: 314.216 °C at 760 mmHg
• Flash Point: 143.833 °C
• Appearance: /
• Density: 1.136 g/cm³
• PKA: 8.23±0.29(Predicted)
• CAS DataBase Reference: 2-Chloro-N-(4-chlorophenethyl)propan-1-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-N-(4-chlorophenethyl)propan-1-aMine(897926-35-1)
• EPA Substance Registry System: 2-Chloro-N-(4-chlorophenethyl)propan-1-aMine(897926-35-1)

Safety Data

• Hazardous Substances Data: 897926-35-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-N-(4-chlorophenethyl)propan-1-aMine is utilized as a pharmaceutical intermediate for the synthesis of various medicinal compounds. Its unique structural properties allow it to serve as a building block in the development of drugs with specific therapeutic targets, potentially contributing to the creation of novel treatments for a range of medical conditions.
Used in Research Applications:
In the field of scientific research, 2-Chloro-N-(4-chlorophenethyl)propan-1-aMine is employed as a research chemical. Its distinct structural features make it a valuable tool for studying the interactions between molecules in biological systems, aiding in the understanding of complex biochemical processes and the discovery of new therapeutic agents.

Upstream product

• 1878-66-6 4-chlorophenylacetic Acid 
• 1030624-36-2 2-(4-chlorophenyl)-N-(2-hydroxypropyl)acetamide 

Relevant articles and documents

8-chloro-1-methyl -2, 3, 4, 5-tetrahydro -1H-3-Benzazepine preparation method

The invention discloses a preparation method of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzoazatropylidene. The preparation method comprises the following steps: firstly, enabling a compound with a formula (III) to react with aluminium chloride to obtain a compound with a formula (II); and carrying out reduction reaction on the compound with the formula (II) under the combined action of sodium borohydride and aluminium chloride used in the step i) to obtain a compound in a formula (I). The invention also discloses a method for preparing a compound with a formula (V) or a salt thereof. The method comprises the following steps: with chlorobenzyl cyanide and 2-chloropropionic acid as raw materials, reacting under the existence of a carboxylic acid activation reagent to generate a compound in a formula (IV); and carrying out reduction reaction on the compound with the formula (IV) under the action of a reducing agent to obtain the compound with the formula (V). Compared with the prior art, the method disclosed by the invention has the advantages of low cost, convenience for operation, safety of production, high yield and the like.

PROCESSES FOR THE PREPARATION OF LORCASERIN

The present invention relates to stable crystalline Form A of lorcaserin hydrochloride of Formula (IA) and processes for its preparation. The invention also relates to processes for the preparation of lorcaserin and pharmaceutically acceptable salts, solvates and hydrates thereof.